JP2009523456A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009523456A5 JP2009523456A5 JP2008551611A JP2008551611A JP2009523456A5 JP 2009523456 A5 JP2009523456 A5 JP 2009523456A5 JP 2008551611 A JP2008551611 A JP 2008551611A JP 2008551611 A JP2008551611 A JP 2008551611A JP 2009523456 A5 JP2009523456 A5 JP 2009523456A5
- Authority
- JP
- Japan
- Prior art keywords
- treating
- drug
- vasopressin
- subject
- gene sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940079593 drug Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims description 6
- 102000004136 Vasopressin Receptors Human genes 0.000 claims description 6
- 108090000643 Vasopressin Receptors Proteins 0.000 claims description 6
- 102000002852 Vasopressins Human genes 0.000 claims description 6
- 108010004977 Vasopressins Proteins 0.000 claims description 6
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims description 6
- 230000004968 inflammatory condition Effects 0.000 claims description 6
- 230000037361 pathway Effects 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 239000000018 receptor agonist Substances 0.000 claims description 6
- 229940044601 receptor agonist Drugs 0.000 claims description 6
- 229960003726 vasopressin Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 description 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76132806P | 2006-01-24 | 2006-01-24 | |
| US79515706P | 2006-04-27 | 2006-04-27 | |
| PCT/CA2007/000111 WO2007085087A1 (en) | 2006-01-24 | 2007-01-24 | Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009523456A JP2009523456A (ja) | 2009-06-25 |
| JP2009523456A5 true JP2009523456A5 (https=) | 2010-03-11 |
Family
ID=38308805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008551611A Pending JP2009523456A (ja) | 2006-01-24 | 2007-01-24 | 重篤な被検体の被検体結果の指標としてのバソプレシン経路多型 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1984546A4 (https=) |
| JP (1) | JP2009523456A (https=) |
| AU (1) | AU2007209725A1 (https=) |
| CA (1) | CA2638773A1 (https=) |
| MX (1) | MX2008009654A (https=) |
| WO (1) | WO2007085087A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009033820A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| EP2197469A2 (en) * | 2007-09-11 | 2010-06-23 | Mondobiotech Laboratories AG | Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection |
| EP2187907A2 (en) * | 2007-09-11 | 2010-05-26 | Mondobiotech Laboratories AG | Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents |
| KR20100057642A (ko) * | 2007-09-11 | 2010-05-31 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 ｃｎｐ-２２ 단독 또는 피살라에민과 배합된 이의 용도 |
| US20100184708A1 (en) * | 2007-09-11 | 2010-07-22 | Dorian Bevec | Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| EP2449104B1 (en) | 2009-06-29 | 2014-06-04 | Luminex Corporation | Chimeric primers with hairpin conformations and methods of using same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2897959B2 (ja) * | 1988-05-20 | 1999-05-31 | エフ．ホフマン―ラ ロシュ アクチェンゲゼルシャフト | 固定化された配列特異的プローブ |
| US6727063B1 (en) * | 1999-09-10 | 2004-04-27 | Millennium Pharmaceuticals, Inc. | Single nucleotide polymorphisms in genes |
| US20060240419A1 (en) * | 2002-05-17 | 2006-10-26 | Yusuke Nakamura | Method of detecting gene polymorphism |
| US20040033582A1 (en) * | 2002-06-03 | 2004-02-19 | Manling-Ma Edmonds | Human single nucleotide polymorphisms |
| CA2519362A1 (en) * | 2003-03-19 | 2004-09-30 | The University Of British Columbia | Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome |
| WO2005038462A1 (en) * | 2003-10-21 | 2005-04-28 | Suntory Limited | Method for prognostic evaluation of carcinoma using anti-p-lap antibody |
| WO2005085273A1 (en) * | 2004-03-04 | 2005-09-15 | The University Of British Columbia | Thrombomodulin (thbd) haplotypes predict outcome of patients |
| EP1723160A4 (en) * | 2004-03-04 | 2008-04-23 | Univ British Columbia | FORECAST OF PATIENT STATUS EVOLUTION USING TOLL-RECEPTOR 2 (TLR-2) HAPLOTYPES |
| CA2479968A1 (en) * | 2004-09-01 | 2006-03-01 | Keith R. Walley | Protein c and endothelial protein c receptor polymorphisms as indicators of patient outcome |
-
2007
- 2007-01-24 WO PCT/CA2007/000111 patent/WO2007085087A1/en not_active Ceased
- 2007-01-24 CA CA002638773A patent/CA2638773A1/en not_active Abandoned
- 2007-01-24 JP JP2008551611A patent/JP2009523456A/ja active Pending
- 2007-01-24 AU AU2007209725A patent/AU2007209725A1/en not_active Abandoned
- 2007-01-24 MX MX2008009654A patent/MX2008009654A/es not_active Application Discontinuation
- 2007-01-24 EP EP07719352A patent/EP1984546A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009523456A5 (https=) | ||
| EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| NO20083562L (no) | Cannabinoidreseptormodulatorer | |
| JP2009513660A5 (https=) | ||
| JP2008245635A5 (https=) | ||
| EP2210092A4 (en) | SEMAPHORINE COMPREHENSIVE COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO ANGIOGENESIS AND SELECTION PROCEDURES THEREFOR | |
| CL2007001131A1 (es) | Compuestos derivados de purina sustituida; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias. | |
| JP2011525990A5 (https=) | ||
| JP2007517055A5 (https=) | ||
| MY153198A (en) | Inhibitors of protein aggregation | |
| CL2007001132A1 (es) | Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias. | |
| JP2007522094A5 (https=) | ||
| WO2008024456A3 (en) | Substituted acylanilides and methods of use thereof | |
| EP2240136A4 (en) | DEVICE FOR TREATING GASTROÖSOPHAGEAL REFLUX (GERD) AND ADIPOSITAS | |
| WO2008050148A3 (en) | Therapy for liver disease | |
| EP1865967A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES | |
| EP2019619A4 (en) | INFLAMMATORY DISEASE PROGRESSION, DIAGNOSTIC AND TREATMENT MONITORING PROCESSES, SYSTEMS, DEVICE AND USE | |
| NO20092398L (no) | Krystallinske former av solvatisert ilaprazol | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| JP2013539454A5 (https=) | ||
| JP2016538270A5 (https=) | ||
| EP2164505A4 (en) | TREATMENT OF CHRONIC LUNG DISEASE | |
| NO20084458L (no) | IL-8-reseptorantagonister | |
| JP2011528248A5 (https=) | ||
| EP3276004A3 (en) | Methods for treating chronic kidney disease |